การป้องกันภาวะคลื่นไส้อาเจียนจากยาเคมีบำบัด
คำสำคัญ:
ภาวะคลื่นไส้อาเจียนจากยาเคมีบำบัดบทคัดย่อ
ภาวะคลื่นไส้อาเจียนจากยาเคมีบำบัด เป็นหนึ่งในอาการไม่พึงประสงค์ที่พบได้บ่อย ส่งผลต่อคุณภาพชีวิตของผู้ป่วยมะเร็งและอาจนำไปสู่เกิดอาการแทรกซ้อนอื่นๆ ภาวะคลื่นไส้อาเจียนจากยาเคมีบำบัดทำให้เกิดปัญหาการไม่ให้ความร่วมมือของผู้ป่วยในการรักษาโรคมะเร็งได้ สมาคมวิชาชีพหลายสถาบันที่เป็นที่ยอมรับในระดับนานาชาติ ได้เสนอแนะแนวทางการป้องกันการเกิดภาวะคลื่นไส้อาเจียนจากยาเคมีบำบัดไว้ แต่ในทางปฏิบัติพบว่าภาวะคลื่นไส้อาเจียนจากยาเคมีบำบัดนั้นยังไม่สามารถป้องกันได้อย่างสมบูรณ์ จึงทำให้มีการพัฒนาแนวทางการป้องกันการเกิดภาวะคลื่นไส้อาเจียนจากยาเคมีบำบัดอย่างต่อเนื่อง อันได้แก่ ปรับปรุงแบบแผนการใช้ยาต้านอาเจียนร่วมกัน 4 ชนิด (quadruplet regimen) การนำยาต้านอาเจียนชนิดใหม่ๆ มาประยุกต์ใช้เพิ่มเติมในสูตรยาป้องกันภาวะคลื่นไส้อาเจียนมาตรฐานที่มีอยู่เดิม สำหรับการป้องกันภาวะคลื่นไส้อาเจียนจากยาเคมีบำบัดด้วยวิธีที่ไม่ใช้ยา ยังต้องการรายงานการศึกษาวิจัยรองรับประสิทธิผลและความปลอดภัยอีกจำนวนมาก เพื่อให้เกิดความมั่นใจสำหรับบุคลากรทางการแพทย์ในการประยุกต์ใช้ในเวชปฏิบัติต่อไป
เอกสารอ้างอิง
1) National Comprehensive Cancer Network. Antiemesis (Version 3.2018). [cited Sep 30, 2018]. Available from: URL:http://www.nccn.org/professionals/physician_gls/pdf/antiemesis.pdf
2) Aapro M, Jordan K, Feyer P. Pathophysiology of Chemotherapy-induced Nausea and Vomiting. London, UK: Springer Healthcare; 2015.
3) Bayo J, Fonseca PJ, Hernando S, Servitja S, Calvo A, Falagan S, et al. Chemotherapy-induced nausea and vomiting: pathophysiology and therapeutic principles. Clin Transl Oncol 2012;14(6):413-22.
4) Hesketh PJ. Chemotherapy-Induced Nausea and Vomiting. N Engl J Med 2008;358(23):2482-94.
5) Hesketh PJ, Kris MG, Basch E, Bohlke K, Barbour SY, Clark-Snow RA, et al. Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol 2017;35(28):3240-61.
6) Walsh D, Davis M, Ripamonti C, Bruera E, Davies A, Molassiotis A. 2016 Updated MASCC/ESMO consensus recommendations: Management of nausea and vomiting in advanced cancer. Support Care Cancer 2017;25(1):333-40.
7) Navari RM, Qin R, Ruddy KJ, Liu H, Powell SF, Bajaj M, et al. Olanzapine for the prevention of chemotherapy-induced nausea and vomiting. N Engl J Med 2016;375:134-42.
8) Gilmore JW, Peacock NW, Gu A, Szabo S, Rammage M, Sharp J, et al. Antiemetic guideline consistency and incidence of chemotherapy-induced nausea and vomiting in US community practice. INSPIRE study. J Onc Pract 2013;10(1):68-74.
9) Khan S. Prevention of chemotherapy-induced nausea and vomiting. US Pharm 2014;39(3):7-11.
10) Wang RZ, Vashistha V, Kaur S, Houchens NW. Serotonin syndrome: preventing, recognizing, and treating it. Cleve Clin J Med 2016;83(11):810-7.
11) Aapro MS, Walko CM. Aprepitant: drug–drug interactions in perspective. Ann Oncol 2010;21(12):2316–23.
12) Navari RM, Aapro M. Antiemetic prophylaxis for chemotherapy-induced nausea and vomiting. N Engl J Med 2016;374:1356-67.
13) Raedler LA. Akynzeo (netupitant and palonosetron), a dual-acting oral agent, approved by the FDA for prevention of chemotherapy-induced nausea and vomiting. Am Health Drug Benefits 2015;8:45-8.
14) Chanthawong S, Subongkot S, Sookprasert A. Effectiveness of olanzapine for the treatment of breakthrough chemotherapy induced nausea and vomiting. J Med Assoc Thai 2014;97(3):349-55.
15) Navari RM. Pharmacological management of chemotherapy-induced nausea and vomiting. Drugs 2009;69(5): 515-33.
16) Lohr L. Chemotherapy-induced nausea and vomiting. Cancer J 2008;14(2):85-93.
17) Institute for Safe Medication Practices. Acute care ISMP medication safety alert. Action needed to prevent tissue injury with IV promethazine. Updated August 10, 2006. [cited Oct 2, 2018]. Available from: URL:http://ismp.org/Newsletters/acutecare/articles/20060810.asp.
18) PDQ Integrative, Alternative, and Complementary Therapies Editorial Board. Cannabis and cannabinoids (PDQ)-health professional version. Bethesda, MD: National Cancer Institute. Updated April 7, 2017. [cited Oct 3, 2018]. Available from: URL:www.cancer.gov/about-cancer/treatment/cam/hp/cannabis-pdq.
19) PDQ Integrative, Alternative, and Complementary Therapies Editorial Board. Acupuncture (PDQ)-health professional version. Bethesda, MD: National Cancer Institute. Updated October 20, 2016. [cited Oct 3, 2018]. Available from: URL:www.cancer.gov/about-cancer/treatment/cam/hp/acupuncture-pdq.
20) Konmun J, Danwilai K, Ngamphaiboon N, Sripanidkulchai B, Sookprasert A, Subongkot S. A phase II randomized double-blind placebo-controlled study of 6-gingerol as an anti-emetic in solid tumor patients receiving moderately to highly emetogenic chemotherapy. Med Oncol 2017;34(4):69.
21) Thamlikitkul L, Srimuninnimit V, Akewanlop C, Ithimakin S, Techawathanawanna S, Korphaisarn K, et al. Efficacy of ginger for prophylaxis of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adriamycin-cyclophosphamide regimen: a randomized, double-blind, placebo-controlled, crossover study. Support Care Cancer 2017;25(2):459-64.
22) Ryan JL, Heckler CE, Roscoe JA, Dakhil SR, Kirshner J, Flynn PJ, et al. Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients. Support Care Cancer 2012;20(7):1479-89.
23) Pillai AK, Sharma KK, Gupta YK, Bakhshi S. Anti-emetic effect of ginger powder versus placebo as an add-on therapy in children and young adults receiving high emetogenic chemotherapy. Pediatr Blood Cancer 2011;56(2):234-8.
24) Panahi Y, Saadat A, Sahebkar A, Hashemian F, Taghikhani M, Abolhasani E. Effect of ginger on acute and delayed chemotherapy-induced nausea and vomiting: a pilot, randomized, open-label clinical trial. Integr Cancer Ther 2012;11(3):204-11.
25) Zick SM, Ruffin MT, Lee J, Normolle DP, Siden R, Alrawi S,et al. Phase II trial of encapsulated ginger as a treatment for chemotherapy-induced nausea and vomiting. Support Care Cancer 2009;17(5):563-72.
26) Fahimi F, Khodadad K, Amini S, Naghibi F, Salamzadeh J, Baniasadi S. Evaluating the effect of zingiber officinalis on nausea and vomiting in patients receiving Cisplatin based regimens. Iran J Pharm Res 2011;10(2):379-84.
27) Bossi P, Cortinovis D, Fatigoni S, Cossu Rocca M, Fabi A, Seminara P, et al. A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin. Ann Oncol 2017;28(10):2547-51.
28) Lyman GH, Greenlee H, Bohlke K, Bao T, DeMichele AM, Deng GE, et al. Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the SIO Clinical Practice Guideline. J Clin Oncol 2018;14(8):495-9.
29) คมสรรค์ พงษ์ภักดี. ประสิทธิภาพของจุดฝังเข็มเน่ยกวาน (NEIGUAN) ในการระงับอาการคลื่นไส้อาเจียน. Region 4-5 Medical Journal. [cited 25Nov.2018]. Available from: https://www.tci-thaijo.org/index.php/reg45/article/view/140429.
30) Garcia MK, McQuade J, Haddad R, Patel S, Lee R, Yang P, et al. Systematic review of acupuncture in cancer care: a synthesis of the evidence. J Clin Oncol 2013;31(7):952-60.
31) Shen J, Wenger N, Glaspy J, Hays RD, Albert PS, Choi C, et al. Electroacupuncture for control of myeloablative chemotherapy-induced emesis: A randomized controlled trial. JAMA 2000;284(21):2755-61.
32) Lotfi-Jam K, Carey M, Jefford M, Schofield P, Charleson C, Aranda S. Nonpharmacologic strategies for managing common chemotherapy adverse effects: a systematic review. J Clin Oncol 2008;26(34):5618-29.
33) Ezzo JM, Richardson MA, Vickers A, Allen C, Dibble SL, Issell BF, et al. Acupuncture-point stimulation for chemotherapy-induced nausea or vomiting. Cochrane Database Syst Rev. 2006;2:CD002285.
34) PDQ Supportive and Palliative Care Editorial Board. Treatment-related nausea and vomiting (PDQ)-health professional version. Bethesda, MD: National Cancer Institute. Updated May 10, 2017. [cited Oct 3, 2018]. Available from: URL:www.cancer.gov/about-cancer/treatment/side-effects/nausea/nausea-hp-pdq.
35) Knudsen P, Herborg H, Mortensen AR, Knudsen M, Hellebek A. Preventing medication errors in community pharmacy: root-cause analysis of transcription errors. Qual Saf Health Care 2007;16(4):285-90.
2) Aapro M, Jordan K, Feyer P. Pathophysiology of Chemotherapy-induced Nausea and Vomiting. London, UK: Springer Healthcare; 2015.
3) Bayo J, Fonseca PJ, Hernando S, Servitja S, Calvo A, Falagan S, et al. Chemotherapy-induced nausea and vomiting: pathophysiology and therapeutic principles. Clin Transl Oncol 2012;14(6):413-22.
4) Hesketh PJ. Chemotherapy-Induced Nausea and Vomiting. N Engl J Med 2008;358(23):2482-94.
5) Hesketh PJ, Kris MG, Basch E, Bohlke K, Barbour SY, Clark-Snow RA, et al. Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol 2017;35(28):3240-61.
6) Walsh D, Davis M, Ripamonti C, Bruera E, Davies A, Molassiotis A. 2016 Updated MASCC/ESMO consensus recommendations: Management of nausea and vomiting in advanced cancer. Support Care Cancer 2017;25(1):333-40.
7) Navari RM, Qin R, Ruddy KJ, Liu H, Powell SF, Bajaj M, et al. Olanzapine for the prevention of chemotherapy-induced nausea and vomiting. N Engl J Med 2016;375:134-42.
8) Gilmore JW, Peacock NW, Gu A, Szabo S, Rammage M, Sharp J, et al. Antiemetic guideline consistency and incidence of chemotherapy-induced nausea and vomiting in US community practice. INSPIRE study. J Onc Pract 2013;10(1):68-74.
9) Khan S. Prevention of chemotherapy-induced nausea and vomiting. US Pharm 2014;39(3):7-11.
10) Wang RZ, Vashistha V, Kaur S, Houchens NW. Serotonin syndrome: preventing, recognizing, and treating it. Cleve Clin J Med 2016;83(11):810-7.
11) Aapro MS, Walko CM. Aprepitant: drug–drug interactions in perspective. Ann Oncol 2010;21(12):2316–23.
12) Navari RM, Aapro M. Antiemetic prophylaxis for chemotherapy-induced nausea and vomiting. N Engl J Med 2016;374:1356-67.
13) Raedler LA. Akynzeo (netupitant and palonosetron), a dual-acting oral agent, approved by the FDA for prevention of chemotherapy-induced nausea and vomiting. Am Health Drug Benefits 2015;8:45-8.
14) Chanthawong S, Subongkot S, Sookprasert A. Effectiveness of olanzapine for the treatment of breakthrough chemotherapy induced nausea and vomiting. J Med Assoc Thai 2014;97(3):349-55.
15) Navari RM. Pharmacological management of chemotherapy-induced nausea and vomiting. Drugs 2009;69(5): 515-33.
16) Lohr L. Chemotherapy-induced nausea and vomiting. Cancer J 2008;14(2):85-93.
17) Institute for Safe Medication Practices. Acute care ISMP medication safety alert. Action needed to prevent tissue injury with IV promethazine. Updated August 10, 2006. [cited Oct 2, 2018]. Available from: URL:http://ismp.org/Newsletters/acutecare/articles/20060810.asp.
18) PDQ Integrative, Alternative, and Complementary Therapies Editorial Board. Cannabis and cannabinoids (PDQ)-health professional version. Bethesda, MD: National Cancer Institute. Updated April 7, 2017. [cited Oct 3, 2018]. Available from: URL:www.cancer.gov/about-cancer/treatment/cam/hp/cannabis-pdq.
19) PDQ Integrative, Alternative, and Complementary Therapies Editorial Board. Acupuncture (PDQ)-health professional version. Bethesda, MD: National Cancer Institute. Updated October 20, 2016. [cited Oct 3, 2018]. Available from: URL:www.cancer.gov/about-cancer/treatment/cam/hp/acupuncture-pdq.
20) Konmun J, Danwilai K, Ngamphaiboon N, Sripanidkulchai B, Sookprasert A, Subongkot S. A phase II randomized double-blind placebo-controlled study of 6-gingerol as an anti-emetic in solid tumor patients receiving moderately to highly emetogenic chemotherapy. Med Oncol 2017;34(4):69.
21) Thamlikitkul L, Srimuninnimit V, Akewanlop C, Ithimakin S, Techawathanawanna S, Korphaisarn K, et al. Efficacy of ginger for prophylaxis of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adriamycin-cyclophosphamide regimen: a randomized, double-blind, placebo-controlled, crossover study. Support Care Cancer 2017;25(2):459-64.
22) Ryan JL, Heckler CE, Roscoe JA, Dakhil SR, Kirshner J, Flynn PJ, et al. Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients. Support Care Cancer 2012;20(7):1479-89.
23) Pillai AK, Sharma KK, Gupta YK, Bakhshi S. Anti-emetic effect of ginger powder versus placebo as an add-on therapy in children and young adults receiving high emetogenic chemotherapy. Pediatr Blood Cancer 2011;56(2):234-8.
24) Panahi Y, Saadat A, Sahebkar A, Hashemian F, Taghikhani M, Abolhasani E. Effect of ginger on acute and delayed chemotherapy-induced nausea and vomiting: a pilot, randomized, open-label clinical trial. Integr Cancer Ther 2012;11(3):204-11.
25) Zick SM, Ruffin MT, Lee J, Normolle DP, Siden R, Alrawi S,et al. Phase II trial of encapsulated ginger as a treatment for chemotherapy-induced nausea and vomiting. Support Care Cancer 2009;17(5):563-72.
26) Fahimi F, Khodadad K, Amini S, Naghibi F, Salamzadeh J, Baniasadi S. Evaluating the effect of zingiber officinalis on nausea and vomiting in patients receiving Cisplatin based regimens. Iran J Pharm Res 2011;10(2):379-84.
27) Bossi P, Cortinovis D, Fatigoni S, Cossu Rocca M, Fabi A, Seminara P, et al. A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin. Ann Oncol 2017;28(10):2547-51.
28) Lyman GH, Greenlee H, Bohlke K, Bao T, DeMichele AM, Deng GE, et al. Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the SIO Clinical Practice Guideline. J Clin Oncol 2018;14(8):495-9.
29) คมสรรค์ พงษ์ภักดี. ประสิทธิภาพของจุดฝังเข็มเน่ยกวาน (NEIGUAN) ในการระงับอาการคลื่นไส้อาเจียน. Region 4-5 Medical Journal. [cited 25Nov.2018]. Available from: https://www.tci-thaijo.org/index.php/reg45/article/view/140429.
30) Garcia MK, McQuade J, Haddad R, Patel S, Lee R, Yang P, et al. Systematic review of acupuncture in cancer care: a synthesis of the evidence. J Clin Oncol 2013;31(7):952-60.
31) Shen J, Wenger N, Glaspy J, Hays RD, Albert PS, Choi C, et al. Electroacupuncture for control of myeloablative chemotherapy-induced emesis: A randomized controlled trial. JAMA 2000;284(21):2755-61.
32) Lotfi-Jam K, Carey M, Jefford M, Schofield P, Charleson C, Aranda S. Nonpharmacologic strategies for managing common chemotherapy adverse effects: a systematic review. J Clin Oncol 2008;26(34):5618-29.
33) Ezzo JM, Richardson MA, Vickers A, Allen C, Dibble SL, Issell BF, et al. Acupuncture-point stimulation for chemotherapy-induced nausea or vomiting. Cochrane Database Syst Rev. 2006;2:CD002285.
34) PDQ Supportive and Palliative Care Editorial Board. Treatment-related nausea and vomiting (PDQ)-health professional version. Bethesda, MD: National Cancer Institute. Updated May 10, 2017. [cited Oct 3, 2018]. Available from: URL:www.cancer.gov/about-cancer/treatment/side-effects/nausea/nausea-hp-pdq.
35) Knudsen P, Herborg H, Mortensen AR, Knudsen M, Hellebek A. Preventing medication errors in community pharmacy: root-cause analysis of transcription errors. Qual Saf Health Care 2007;16(4):285-90.
เผยแพร่แล้ว
2019-02-20
รูปแบบการอ้างอิง
1.
Chanthawong S. การป้องกันภาวะคลื่นไส้อาเจียนจากยาเคมีบำบัด. SRIMEDJ [อินเทอร์เน็ต]. 20 กุมภาพันธ์ 2019 [อ้างถึง 24 ธันวาคม 2025];34(1):115-26. available at: https://li01.tci-thaijo.org/index.php/SRIMEDJ/article/view/173343
ฉบับ
ประเภทบทความ
Review Articles
